There were recent updates posted to clinical trials.gov for zen-3694. The earliest trial readouts are now scheduled for 12/24 and 2025. It will be a another year until Zenith is  poised for a registering enabling trial and in a position to fund RVX.

"I think we will never know the truth as to if discussions are or are not taking place. Our first clue will probably be how the debenture is dealt with."

You are correct - in less then a month we will get that readout.